Search clinical trials for: placebo TCZ

Total 54781 results

Hoffmann-La Roche

Completed

A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia (COVACTA)

COVID-19 Pneumonia

United States, Spain, Denmark, Netherlands, Canada, Germany, Italy, France, United Kingdom
University Hospital Inselspital, Berne
Roche Pharma AG

Terminated

Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) (CORON-ACT)

SARS-CoV-2 Infection

Switzerland
University Hospital, Brest
Chugai Pharmaceutical

Completed

Tocilizumab Effect iN pOlymyalgia Rheumatica (TENOR)

Polymyalgia Rheumatica

France
National Institute of Allergy and Infectious Diseases...
PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)

Completed

Tocilizumab (TCZ) in New-onset Type 1 Diabetes (EXTEND)

Type 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes Mellitus

United States, Australia
LEO Pharma

Not yet recruiting

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis (TRAPEDS 2)

Atopic Dermatitis

United States
Novartis Pharmaceuticals

Terminated

A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients (ZESTExt)

Atopic Dermatitis

United Kingdom, Germany, Russian Federation, Taiwan, Belgium, Netherlands, Japan, Finland, Slovakia, United States, Iceland, Canada, Poland
Wenjie Zheng

Terminated

Tocilizumab for the Treatment of Refractory Behcet's Uveitis

Behcet Syndrome | Uveitis

China
Children's Hospital of Philadelphia

Withdrawn

Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH)

Hemophagocytic Lymphohistiocytosis

United States
Jarmo Oksi

Completed

COVID-19: Salvage TOcilizumab as a Rescue Measure (COVIDSTORM)

Covid19

Finland
Case Western Reserve University

Completed

AIDS 347: IL-6 Blockade in Treated HIV Infection (IL-6)

HIV Infections

United States
Shanghai University of Traditional Chinese Medicine
Fudan University; Shanghai Zhongshan Hospital; Ruijin Hospital; Shanghai Chest... and other collaborators

Not yet recruiting

Clinical Study on the Prevention of Driver Gene Negative II-IIIa Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

Lung Cancer

China
Henan University of Traditional Chinese Medicine

Unknown

Effects of Traditional Chinese Medicine on AECOPD Patients

Pulmonary Disease, Chronic Obstructive | Medicine, Chinese Traditional | Acute Exacerbation
Henan University of Traditional Chinese Medicine

Recruiting

Effects of Traditional Chinese Medicine on Outcomes in Patients With AECOPD Risk Window

Chronic Obstructive Pulmonary Disease

China
Teijin America, Inc.
Parexel

Completed

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Memorial Sloan Kettering Cancer Center

Recruiting

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Metastatic Pancreatic Cancer | Metastatic Pancreatic Ductal Adenocarcinoma | Primary Pancreatic Ductal Adenocarcinoma

United States
Xinnate AB
Region Skane

Completed

Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.

Blister | Epidermolysis Bullosa | Wound of Skin | Varicose Ulcer of Lower Limb

Sweden
Peking University Cancer Hospital & Institute

Recruiting

The Role of TCM on ERAS of Rectal Cancer Patients (RCT)

Rectal Cancer

China
Henan University of Traditional Chinese Medicine

Unknown

Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe Pneumonia

Community-Acquired Infections

China
University of Nove de Julho

Not yet recruiting

TCA Peel and Photobiomodulation for Hand Rejuvenation

Skin Aging

Brazil
Theraclone Sciences, Inc.

Unknown

Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza

Influenza

United Kingdom
LEO Pharma

Completed

Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis (ECZTRA 8)

Atopic Dermatitis

Japan
Chung Shan Medical University

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of Traditional Chinese Medicine in Sjögren's Syndrome.

Sjögren's Syndrome

Taiwan
Chinese University of Hong Kong

Completed

Herbal Preparation Used as Adjuvant Therapy on Diabetic Ulcers

Amputation | Diabetic Foot Ulcer

China
Vertex Pharmaceuticals Incorporated

Completed

A Study to Evaluate Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Adults With Cystic Fibrosis

Cystic Fibrosis

United Kingdom
AstraZeneca

Completed

A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers

Healthy

Japan
University of Florida

Completed

Transcranial Doppler Ultrasound Monitoring During Flow-Diverter Embolization

Intracranial Aneurysm | Aneurysm, Intracranial | Giant Intracranial Aneurysm

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Prochlorperazine in Migraine (Out Patient)

Migraine Headache | Aura

United States
Targacept Inc.

Completed

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

Schizophrenia | Cognitive Dysfunction | Negative Symptoms

United States, Serbia, Ukraine, Russian Federation, Hungary, Romania
Targacept Inc.

Completed

Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis

Gastroparesis

United States
Targacept Inc.

Completed

Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome

United Kingdom
Targacept Inc.

Completed

TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia

Schizophrenia | Cognitive Dysfunction

United States, India
Targacept Inc.

Completed

TC-6987 for the Treatment of Mild to Moderate Asthma

Asthma

United States
Targacept Inc.

Terminated

TC-5214 as Augmentation Therapy in Patients With Refractory Hypertension

Refractory Hypertension

United States
AstraZeneca

Completed

A Study to Assess Safety and Tolerability as Well as Absorption and Excretion of TC-5214 in Medically Stable Elderly Subjects

Elderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.

Sweden
Hoffmann-La Roche

Completed

A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

France, Israel, Italy, Hong Kong, Switzerland, Canada, Germany, Mexico, Austria, Thailand, Singapore, Hungary, Bulgaria, Australia, Argentina, Slovakia, Brazil
Peking University Cancer Hospital & Institute

Active, not recruiting

RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy (TCM)

Cancer-related Problem/Condition

China
Theraclone Sciences, Inc.

Completed

Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza

Influenza, Human

United States
Targacept Inc.

Completed

Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Targacept Inc.

Completed

Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease

Alzheimer's Disease

United States
Targacept Inc.

Completed

Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
Targacept Inc.

Completed

Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder

Overactive Bladder

United States
Chandan K Sen

Terminated

Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars

Scar

United States
Targacept Inc.

Completed

Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)

ADHD

United States
China Medical University Hospital

Completed

Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect

Advanced Lung Adenocarcinoma
Hoffmann-La Roche

Completed

A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States, Korea, Republic of, Canada, United Kingdom, Germany, Australia, Poland, Finland, France, Spain, Switzerland, Czechia, Netherlands, Taiwan
Woman's Health University Hospital, Egypt

Completed

Ultrasound Guided Intra-uterine Device Insertion

Contraception

Egypt
Cara Therapeutics, Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis (KIND-1)

Pruritus | Atopic Dermatitis

United States
Wockhardt
Clinartis, LLC

Completed

To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ)

Antibiotics Causing Adverse Effects in Therapeutic Use

United States
Vertex Pharmaceuticals Incorporated

Completed

A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis

Cystic Fibrosis

United States, Israel, Ireland, United Kingdom
Atacama Therapeutics

Completed

Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis

Palmar Hyperhidrosis

United States

Search clinical trials for: placebo TCZ

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations